Elena De Ponti

Azienda Ospedaliera San Gerardo

Papers

1

Total Citations

4

H-Index

1

About

Elena De Ponti is a leading researcher in gynecologic oncology, with a focused expertise in endometrial cancer prognosis and treatment. Her work centers on identifying histopathological factors that influence survival outcomes, particularly the role of lymphovascular space invasion (LVSI) in early-stage disease. Her most cited study, the SLYMEC II analysis, provides critical insights into how LVSI impacts overall survival in apparent early-stage endometrioid endometrial cancer, offering clinicians a refined risk stratification tool. This research, published in 2025 and already garnering 4 citations, underscores her ability to address pressing clinical questions with rigorous methodology. De Ponti’s contributions are shaping surgical decision-making and adjuvant therapy guidelines, bridging the gap between pathology and patient-centered care. Her work is widely recognized for its translational impact, helping to personalize treatment for women with gynecologic malignancies. As a rising voice in her field, De Ponti continues to advance evidence-based oncology, making her research essential reading for clinicians and scientists dedicated to improving outcomes in endometrial cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
SLYMEC II study: Overall survival analysis of the impact of LVSI in apparent early stage endometrioid endometrial cancer
4 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: Azienda Ospedaliera San Gerardo

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago